/ /

  • linkedin
  • Increase Font
  • Sharebar

    Prevent Blindness accepting investigator award applications


    Chicago—Prevent Blindness is now accepting applications for its 2014 Joanne Angle Investigator Award.

    The award—which was recently renamed to honor Joanne Angle, who served with the Association for Research in Vision and Ophthalmology, as well as the national Board of Directors for Prevent Blindness—is a research grant provided annually to a public health project that seeks to help save sight.

    The investigator award program has awarded more than $1 million to eye and vision research projects since its inception in 2003.

    The deadline for the 11th annual investigator award is March 31. Grants are for a 1-year period, up to $30,000, reviewed by a panel of scientists, and commence on July 1.

    “Supporting eye and vision research today is crucial to finding the answers to blinding eye diseases and conditions,” said Hugh R. Parry, president and chief executive officer of Prevent Blindness. “By starting the next decade of this sight-saving program, we can help to make a real difference in the lives those who have, or potentially could have, significant vision loss.

    “By renaming this initiative as the Joanne Angle Investigator Award, we honor Ms. Angle’s legacy as a pioneer and leader in this important field,” he added.

    For more information or to submit an application for the award, click here.


    For more articles in this issue of Ophthalmology Times eReport, click here.



    To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.


    Rose Schneider Krivich
    Rose is the content specialist for Medical Economics.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results